- PR Newswire•20 hours ago
Lifshitz & Miller LLP Announces Investigation of Aratana Therapeutics, Inc., FXCM Inc., Innocoll Holdings plc, Momenta Pharmaceuticals, Inc., Omnicom Group Inc., Perrigo Company plc, Santander Consumer USA Holdings Inc. and The Interpublic Group of Companies, Inc.
NEW YORK, March 24, 2017 /PRNewswire/ -- Aratana Therapeutics, Inc. (PETX) Lifshitz & Miller announces investigation on behalf of PETX investors concerning PETX's statements about the commercial viability ...
- PR Newswire•18 days ago
INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving the Board of Momenta Pharmaceuticals, Inc. -- MNTA
NEW YORK, March 7, 2017 /PRNewswire/ -- Levi & Korsinsky announces it has commenced an investigation of Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA). On February 17, 2017, Momenta announced that a contracted ...
- Reuters•25 days ago
The U.S. Food and Drug Administration said Pfizer Inc's process for manufacturing sterile injectable drugs at a plant in McPherson, Kansas, was "out of control" and put patients at risk, according to a warning letter made public on Tuesday. In the Feb. 14 letter, the FDA said several products were contaminated with multiple foreign particulates and that the injectable antibiotic vancomycin had been compromised by cardboard pieces. The FDA warned the company it had failed to take corrective action.
MNTA : Summary for Momenta Pharmaceuticals, Inc. - Yahoo Finance
Momenta Pharmaceuticals, Inc. (MNTA)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||12.50 x 300|
|Day's Range||13.30 - 13.75|
|52 Week Range||8.16 - 19.90|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-44.28|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|